Hydromorphone Hydrochloride Tablet, Extended Release
Product Images NDC 31722-119

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 31722-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

12 mg (12 mg 100 Ct)

12 mg (12 mg 100 Ct)
This is a medication called HYDROmorphone Hydrochloride Extended-Release Tablets which comes in a bottle of 100 tablets. It is intended for opioid-tolerant patients and needs to be dispensed with a medication guide by a pharmacist only. Each tablet contains 12 mg of Hydromorphone Hydrochloride to be taken once daily. Patients should not break, crush, or chew the tablet but swallow it whole. It should be stored at 68°F to 77°F or 20°C to 25°C. The manufacturer is Camber Pharmaceuticals, Inc. located in Piscataway, NJ and it's manufactured by Ascent Pharmaceuticals, Inc. located in Central Islip, NY.*
FDA Label Image

16 mg (16 mg 100 Ct)

16 mg (16 mg 100 Ct)
This is a description of a medication called HYDROmorphone Hydrochloride, which comes in extended-release tablets taken once daily. Each tablet contains 16 mg of Hydromorphone Hydrochloride and should be swallowed whole without breaking, crushing, or chewing. The package insert provides dosing information and the medication should be stored at 20° to 25°C. Dispense the medication guide provided separately to each patient. The medication was manufactured by Ascent Pharmaceuticals, Inc. in Central Islip, NY, and distributed by Camber Pharmaceuticals in Piscataway, NJ.*
FDA Label Image

32 mg (32 mg 100 Ct)

32 mg (32 mg 100 Ct)
Each tablet of CAMBEI contains Hydromorphone Hydrochloride of 32mg. The tablets are to be swallowed whole and should not be chewed or broken. CAMBEI is an extended-release tablet that should be stored in a controlled room temperature between 20° to 25° Celsius. The medicine is meant for opioid-tolerant patients and the medication guide should be provided separately to each patient. CAMBEI is manufactured by Ascent Pharmaceuticals, Inc. and distributed by Camber Pharmaceuticals, Inc. in Piscataway, NJ.*
FDA Label Image

8 mg (8 mg 100 Ct)

8 mg (8 mg 100 Ct)
FDA Label Image

Fig-1 (Figure 1)

Fig-1 (Figure 1)
FDA Label Image

Fig-2 (Figure 2)

Fig-2 (Figure 2)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Table-5 (Table 5)

Table-5 (Table 5)
This text appears to be a table with different dosages for a certain medical regimen. It includes different parameters such as hours, concentration, and AUC (Area Under the Curve) for different dosages. Additionally, there are some values described as NA (not applicable) and some median and steady-state results for a specific day. The numbers seem to represent concentration levels in ng/mL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.